| Theme | Innovation of Renal Replacement Therapy (RRT) -- What points should be changed ? | |
|---|---|---|
| Title | Questions concerning peritoneal dialysis innovations | |
| Publish Date | 2008/06 | |
| Author | Takenori Funaki | Division of Blood Purification and Nephrology, Department of Medicine, Tokyo Women's Medical University Medical Center East |
| [ Summary ] | It is often necessary to cease peritoneal dialysis (PD) due to adverse side effects or other diseases, which may complicate treatment. Infections of the peritoneum or decreased peritoneal function are the primary factors contributing to difficulties with this treatment. SMAP (stepwise initiation of peritoneal dialysis using the Moncrief and Popovich technique) has played a major role in reducing the number of infections at peritoneal access points. It is now hoped that improved long term clinical results may be achieved by employing less acidic or acid free GDP dialysis solutions, as well as new icodextrin containing solutions. Complementary PD-HD therapy also shows promise as an effective treatment. It is now possible to implement computer software to taylor specific programs, which will meet the needs of individual dialysis patients. However, ongoing efforts must be made to provide better QOL for long-term PD patients. | |